Lausanne-based HealthTech startup ReproNovo, a company innovating treatments for reproductive medicine and women’s health
ReproNovo has raised €57M across 1 funding round from 5 investors, most recently a Series A round in May 2025. Based in Lausanne, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-21 | Series A | €57M |
| ALSA Ventures,AXA IM Alts,Jeito Capital,M Ventures,Ysios Capital |
| View deal → |
